{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:14:10Z","timestamp":1791332050092,"version":"4.3.1"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005815","name":"Firland Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005815","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fred Hutch Center for AIDS Research"},{"DOI":"10.13039\/501100012264","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012264","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Seattle Tuberculosis Research Advancement Center"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In trials, 3-month weekly rifapentine and isoniazid (3HP) showed higher adherence and completion than the 6-month daily isoniazid (6H) regimen for TB preventive treatment (TPT). However, programmatic outcome data remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We evaluated the TPT cascade among people with HIV (PWH) aged \u226515 years newly enrolled in HIV care in western Kenya. Initiation and completion of 6H (Jan\u2013Sept 2022) were compared to 3HP (Oct 2022\u2013Sept 2023) using \u03c72 tests. Correlates of noninitiation and noncompletion were assessed using Poisson regression with generalized linear models. Mortality within 24 months was evaluated using Cox proportional hazards regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 1930 PWH (median age 33 years [IQR=27\u201341]), 65.8% were female, and 19.5% had advanced HIV disease (AHD) at enrollment. Overall, 1922 (99.6%) were screened for active TB, of whom 1790 (97.5%) were TPT-eligible; 1577 (88.1%) of these initiated TPT. TPT initiation was higher with 3HP than 6H (89.8% vs 84.2%; P &amp;lt; .001). TPT completion was similar for 3HP and 6H (89.2% vs 88.8% P = .77). TB incidence (per 1000 person-months) was lower among TPT-completers (0.22; 95% CI 0.15\u20130.35) than those who neither initiated (4.25; 95% CI 1.77\u201310.23) nor completed TPT (3.75; 95% CI 2.49\u20135.64). AHD was associated with higher risk of TPT noninitiation (aRR = 2.14; 95% CI 1.59\u20132.87) and noncompletion of both 6H (aRR = 2.56; 95% CI: 1.55\u20134.23) and 3HP (aRR = 1.68; 95% CI 1.07\u20132.63).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TPT initiation was significantly higher after 3HP implementation. However, 3HP completion was similar to 6H. Targeted interventions are needed to support 3HP completion, particularly in PWH with AHD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofag416","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:47:48Z","timestamp":1782920868000},"source":"Crossref","is-referenced-by-count":1,"title":["Outcomes of the Three-month Weekly Isoniazid With Rifapentine (3HP) Versus the Six-month Isoniazid Preventive Therapy (6H) Among People Newly Enrolled in HIV Care in Western Kenya"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1634-0531","authenticated-orcid":false,"given":"Dickens O","family":"Onyango","sequence":"first","affiliation":[{"name":"Department of Health , County Government of Kisumu, Kisumu ,","place":["Kenya"]},{"name":"Department of Research and Programs, Kenyatta National Hospital , Nairobi ,","place":["Kenya"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6446-0395","authenticated-orcid":false,"given":"Jerphason O","family":"Mecha","sequence":"additional","affiliation":[{"name":"Centre for Respiratory Disease Research, Kenya Medical Research Institute , Nairobi ,","place":["Kenya"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5067-0788","authenticated-orcid":false,"given":"Lilian N","family":"Njagi","sequence":"additional","affiliation":[{"name":"Centre for Respiratory Disease Research, Kenya Medical Research Institute , Nairobi ,","place":["Kenya"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samson","family":"Aoro","sequence":"additional","affiliation":[{"name":"Department of Research and Programs, Kenyatta National Hospital , Nairobi ,","place":["Kenya"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Malika","sequence":"additional","affiliation":[{"name":"Department of Health , County Government of Kisumu, Kisumu ,","place":["Kenya"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6571-8927","authenticated-orcid":false,"given":"John","family":"Kinuthia","sequence":"additional","affiliation":[{"name":"Department of Research and Programs, Kenyatta National Hospital , Nairobi ,","place":["Kenya"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4301-1573","authenticated-orcid":false,"given":"Grace","family":"John-Stewart","sequence":"additional","affiliation":[{"name":"Department of Global Health, University of Washington , Seattle, Washington ,","place":["USA"]},{"name":"Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington , Seattle, Washington ,","place":["USA"]},{"name":"Department of Epidemiology, University of Washington , Seattle, Washington ,","place":["USA"]},{"name":"Department of Pediatrics, University of Washington , Seattle, Washington ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9809-5997","authenticated-orcid":false,"given":"Sylvia M","family":"LaCourse","sequence":"additional","affiliation":[{"name":"Department of Global Health, University of Washington , Seattle, Washington ,","place":["USA"]},{"name":"Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington , Seattle, Washington ,","place":["USA"]},{"name":"Department of Epidemiology, University of Washington , Seattle, Washington ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"2026071413465346600_ofag416-B1","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","volume":"2010","author":"Akolo","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2026071413465346600_ofag416-B2","author":"Centers for Disease Control and Prevention"},{"key":"2026071413465346600_ofag416-B3","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1186\/s12889-020-09902-z","article-title":"Evaluation of the uptake of tuberculosis preventative therapy for people living with HIV in Namibia: a multiple methods analysis","volume":"20","author":"Roscoe","year":"2020","journal-title":"BMC Public Health"},{"key":"2026071413465346600_ofag416-B4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2334-14-91","article-title":"Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta-analysis","volume":"14","author":"Ayieko","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2026071413465346600_ofag416-B5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12879-017-2377-x","article-title":"Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: a systematic review with network meta-analyses","volume":"17","author":"Pease","year":"2017","journal-title":"BMC Infect Dis"},{"key":"2026071413465346600_ofag416-B6","author":"World Health Organization"},{"key":"2026071413465346600_ofag416-B7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209098","article-title":"Kenya tuberculosis prevalence survey 2016: challenges and opportunities of ending TB in Kenya","volume":"13","author":"Enos","year":"2018","journal-title":"PLoS One"},{"key":"2026071413465346600_ofag416-B8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188235","article-title":"Reduction of HIV-associated excess mortality by antiretroviral treatment among tuberculosis patients in Kenya","volume":"12","author":"Onyango","year":"2017","journal-title":"PLoS One"},{"key":"2026071413465346600_ofag416-B9","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/jpc.14359","article-title":"Barriers to the implementation of isoniazid preventive therapy for tuberculosis in children in endemic settings: a review","volume":"55","author":"Grace","year":"2019","journal-title":"J Paediatr Child Health"},{"key":"2026071413465346600_ofag416-B10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0003306","article-title":"Optimizing the cascade of prevention to protect people from tuberculosis: a potential game changer for reducing global tuberculosis incidence","volume":"4","author":"Matteelli","year":"2024","journal-title":"PLOS Glob Public Health"},{"key":"2026071413465346600_ofag416-B11","author":"World Health Organization"},{"key":"2026071413465346600_ofag416-B12","author":"World Health Organization"},{"key":"2026071413465346600_ofag416-B13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/QAI.0000000000001461","article-title":"Evaluation of the isoniazid preventive therapy care cascade among HIV-positive female sex workers in Mombasa, Kenya","volume":"76","author":"LaCourse","year":"2017","journal-title":"J Acquir Immune Defic syndr"},{"key":"2026071413465346600_ofag416-B14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182185","article-title":"Child contact management in high tuberculosis burden countries: a mixed-methods systematic review","volume":"12","author":"Szkwarko","year":"2017","journal-title":"PLoS One"},{"key":"2026071413465346600_ofag416-B15","author":"Ministry of Health"},{"key":"2026071413465346600_ofag416-B16","author":"National AIDS and STI Control Programme (NASCOP)"},{"key":"2026071413465346600_ofag416-B17","author":"Ministry of Health"},{"key":"2026071413465346600_ofag416-B18","author":"Ministry of Health"},{"key":"2026071413465346600_ofag416-B19","author":"Ministry of Health"},{"key":"2026071413465346600_ofag416-B20","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25939","article-title":"Drop-offs in the isoniazid preventive therapy cascade among children living with HIV in western Kenya, 2015-2019","volume":"25","author":"Onyango","year":"2022","journal-title":"J Int AIDS Soc"},{"key":"2026071413465346600_ofag416-B21","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/M17-1150","article-title":"Self-administered versus directly observed once-weekly isoniazid and rifapentine treatment of latent tuberculosis infection: a randomized trial","volume":"167","author":"Belknap","year":"2017","journal-title":"Ann Intern Med"},{"key":"2026071413465346600_ofag416-B22","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2471\/BLT.23.290396","article-title":"Health literacy and tuberculosis control: systematic review and meta-analysis","volume":"102","author":"Chauhan","year":"2024","journal-title":"Bull World Health Organ"},{"key":"2026071413465346600_ofag416-B23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234588","article-title":"Outcomes of isoniazid preventive therapy among people living with HIV in Kenya: a retrospective study of routine health care data","volume":"15","author":"Karanja","year":"2020","journal-title":"PLoS One"},{"key":"2026071413465346600_ofag416-B24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024286","article-title":"Factors affecting the acceptability of isoniazid preventive therapy among healthcare providers in selected HIV clinics in Nairobi county, Kenya: a qualitative study","volume":"8","author":"Wambiya","year":"2018","journal-title":"BMJ Open"},{"key":"2026071413465346600_ofag416-B25","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1097\/QAI.0000000000000264","article-title":"Decentralization of HIV care and treatment services in Central Province, Kenya","volume":"67","author":"Reidy","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026071413465346600_ofag416-B26","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-3156.2010.02503.x","article-title":"Outcome assessment of decentralization of antiretroviral therapy provision in a rural district of Malawi using an integrated primary care model","volume":"15","author":"Chan","year":"2010","journal-title":"Trop Med Int Health"},{"key":"2026071413465346600_ofag416-B27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2025-100927","article-title":"ThiPhiSA: new pathways to TB prevention from community screening - a household-randomised controlled trial in KwaZulu-Natal, South Africa","volume":"15","author":"Misra","year":"2025","journal-title":"BMJ Open"},{"key":"2026071413465346600_ofag416-B28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s43058-023-00390-x","article-title":"The systems analysis and improvement approach: specifying core components of an implementation strategy to optimize care cascades in public health","volume":"4","author":"Gimbel","year":"2023","journal-title":"Implement Sci Commun"},{"key":"2026071413465346600_ofag416-B29","doi-asserted-by":"crossref","first-page":"e1080","DOI":"10.1016\/S2214-109X(17)30372-8","article-title":"Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial","volume":"5","author":"Badje","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2026071413465346600_ofag416-B30","first-page":"413","article-title":"Isoniazid preventive therapy adherence and its predictors among soldiers on HIV antiretroviral therapy at a General Military Hospital in Uganda","volume":"16","author":"Moses","year":"2024","journal-title":"HIV AIDS (Auckl)"},{"key":"2026071413465346600_ofag416-B31","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1016\/S2352-3018(25)00246-2","article-title":"Inpatient initiation of tuberculosis preventive therapy with 1 month of isoniazid and rifapentine for adults with advanced HIV disease and cryptococcal meningitis (IMPROVE): a non-inferiority, randomised controlled trial","volume":"13","author":"Ellis","year":"2026","journal-title":"Lancet HIV"},{"key":"2026071413465346600_ofag416-B32","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.5588\/ijtld.18.0168","article-title":"Three-month weekly rifapentine plus isoniazid for tuberculosis preventive treatment: a systematic review","volume":"22","author":"Hamada","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026071413465346600_ofag416-B33","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1093\/cid\/cix1141","article-title":"Causes and timing of mortality and morbidity among late presenters starting antiretroviral therapy in the REALITY trial","volume":"66","author":"Post","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2026071413465346600_ofag416-B34","doi-asserted-by":"crossref","first-page":"558","DOI":"10.15585\/mmwr.mm6621a3","article-title":"Trends in prevalence of advanced HIV disease at antiretroviral therapy enrollment - 10 countries, 2004-2015","volume":"66","author":"Auld","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026071413465346600_ofag416-B35","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1093\/cid\/cix1138","article-title":"The persistent challenge of advanced HIV disease and AIDS in the era of antiretroviral therapy","volume":"66","author":"Calmy","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2026071413465346600_ofag416-B36","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1093\/cid\/cix1140","article-title":"The continuing burden of advanced HIV disease over 10 years of increasing antiretroviral therapy coverage in South Africa","volume":"66","author":"Osler","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2026071413465346600_ofag416-B37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000391","article-title":"Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies","volume":"8","author":"Getahun","year":"2011","journal-title":"PLoS Med"},{"key":"2026071413465346600_ofag416-B38","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1093\/cid\/ciy045","article-title":"Persistent high burden of advanced HIV disease among patients seeking care in South Africa's National HIV Program: data from a nationwide laboratory cohort","volume":"66","author":"Carmona","year":"2018","journal-title":"Clin Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofag416\/68693388\/ofag416.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/7\/ofag416\/68693388\/ofag416.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/7\/ofag416\/68693388\/ofag416.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T17:47:06Z","timestamp":1784051226000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofag416\/8724399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofag416","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,7,1]]},"article-number":"ofag416"}}